id,filing_uuid,filing_type,registrant_name,registrant_id,client_name,filing_year,filing_period,issue_code,specific_issues,government_entities,income_amount,expense_amount,is_no_activity,is_termination,received_date
3489618,44a0c2cf-e748-4227-b6cd-dca52bca6480,Q4,AMERICAN ASSOCIATION FOR CANCER RESEARCH,400601833,AMERICAN ASSOCIATION FOR CANCER RESEARCH,2025,fourth_quarter,BUD,"FY 2026 Appropriations for NIH, NCI, CDC, FDA, and related cancer research and prevention accounts.","HOUSE OF REPRESENTATIVES,SENATE",,100000,0,0,2026-01-16T14:08:45-05:00
3489619,44a0c2cf-e748-4227-b6cd-dca52bca6480,Q4,AMERICAN ASSOCIATION FOR CANCER RESEARCH,400601833,AMERICAN ASSOCIATION FOR CANCER RESEARCH,2025,fourth_quarter,MED,"Cancer research generally Diversity in clinical trials Drug approval Pediatric cancer detection, treatment, prevention","HOUSE OF REPRESENTATIVES,SENATE",,100000,0,0,2026-01-16T14:08:45-05:00
3489620,44a0c2cf-e748-4227-b6cd-dca52bca6480,Q4,AMERICAN ASSOCIATION FOR CANCER RESEARCH,400601833,AMERICAN ASSOCIATION FOR CANCER RESEARCH,2025,fourth_quarter,TOB,Tobacco control and prevention Tobacco cessation,"HOUSE OF REPRESENTATIVES,SENATE",,100000,0,0,2026-01-16T14:08:45-05:00
3489621,44a0c2cf-e748-4227-b6cd-dca52bca6480,Q4,AMERICAN ASSOCIATION FOR CANCER RESEARCH,400601833,AMERICAN ASSOCIATION FOR CANCER RESEARCH,2025,fourth_quarter,HCR,Reducing cancer disparities Cancer survivorship Preventing HPV-related cancers,"HOUSE OF REPRESENTATIVES,SENATE",,100000,0,0,2026-01-16T14:08:45-05:00